Etiqueta: Industry

BYD posts first monthly sales decline in 2025 as rival EV makers set record deliveries amid strong market competition in China.

The global automotive industry in 2025 has found itself at the eye of a geopolitical storm. Major markets—including Europe, the United States, and China—have experienced heavy-handed policy interventions in the first three quarters of the year, forcing a rewrite of global supply chain rhythms. While overall vehicle sales have held relatively steady, automakers and their suppliers are seeing weaker order volumes and declining profitability.

BYD just took its first hit in 19 months. The automaker’s September sales dropped 5.5% year-on-year, with just over 396,000 cars sold, according to its Hong Kong stock filing on Wednesday. This is the first year-on-year decline since the streak began, and it’s happening while China’s domestic demand weakens and government pressure ramps up against […]

Self-driving vehicles are looking to be an increasingly larger reality on the road as automobile developers look to develop more advanced levels.

We spotted the highly anticipated BYD Denza B5 off-roader testing in Sydney ahead of its November 2025 arrival.

The automotive industry is a critical pillar of China’ s national economy. With an exceptionally long industrial chain - extending upstream to resource development, spanning midstream through...

Support CleanTechnica's work through a Substack subscription or on Stripe. This is my second article on the recent visit of a large but select group of journalists to BYD’s Shenzhen factory and headquarters, and to the Zhengzhou tech center in China. I saw and experienced BYD’s groundbreaking electric vehicle innovations ... [continued]

Turin’s air was cleaner than it during its industrial peak, but around half the 50-plus brands and more than half the production cars on show were Chinese.

Stocks to watch this morning include CoreWeave (CRWV), the NVIDIA (NVDA)-backed AI cloud scaler, which is rising after some big swings in recent weeks. In the pharmaceutical sector, AstraZeneca (AZN) gains as it announces plans to list in New York, while GSK (GSK) and UCB SA (UCB.BR) are up on appointing a new CEO and positive trial results, respectively. And it's a high-stakes moment for Tesla (TSLA), BYD (1211.HK) and other makers of electric vehicles, amid a global slowdown and as a $7,500 tax credit comes to an end in the US. For more live coverage of markets watch the full episode of Market Sunrise and head to Yahoo Finance.